Quality measurement is here to stay, but a JAMA viewpoint asks if anyone is keeping tabs on the costs of measurement. In less than 20 years, the need to measure healthcare quality has become obvious.

Whether we realize it or not, the performance review as we have come to know it is dead. Yes, dead. And what’s more, we’re mostly to blame. Why you might ask? It’s simple, we’ve been doing it wrong.

Editor’s note: Dane Atkinson is the CEO of SumAll. Sixteen years ago, I thought that owning a bar and running a tech startup simultaneously would be a great match for my ADD. Ultimately, what made the ...